未经授权:了解由中心体蛋白290(CEP290)基因突变导致的先天性双眼盲中重建视锥细胞功能的后果。
未经评估:第1b/2阶段开放标签,多中心,多剂量,剂量递增试验。
UNASSIGNED:招募时具有光感(LP)视力的5名参与者的同质亚组(年龄范围,15-41岁)进行详细分析。4名参与者的病史与先天性双眼失明一致,而1名参与者在生命早期表现出空间视觉的证据,但后来丧失了。
UNASSIGNED:参与者接受单次玻璃体内注射sepofarsen(160或320μg)到研究眼中。
未经评估:全场刺激测试(FST),视敏度(VA),在基线和注射后3个月测量一过性瞳孔反射(TPLR)。
UNASSIGNED:所有5名LP视力参与者均表现出严重的FST和TPLR异常。在基线,对照和研究眼的FST阈值估计值分别为0.81和1.0logcd/m2,分别。3个月时,与基线相比,研究眼睛显示出-1.75log的大平均改善(P<0.001),而未经治疗的对照眼与基线相当。蓝色减去红色FST值与0值无差异(P=0.59),与残余视力的圆锥调解兼容。在基线,TPLR响应幅度和潜伏期估计为0.39mm和0.72秒,分别,为了控制眼睛,0.28毫米和0.78秒,分别,研究的眼睛。3个月时,研究的眼睛显示,与基线相比,振幅平均改善0.44mm,潜伏期平均加速0.29秒(P<0.001),而对照眼与基线相比没有显着变化。在1名参与者中进行的专门测试确认并扩展了所有5名参与者的标准化结果。
未经批准:根据主观和客观证据,玻璃体内sepofarsen改善了具有LP视力的个体的光敏感性。然而,在早期神经发育过程中,有视觉经历史的人可能优先将增加的光敏感性转化为改善的空间视觉。如果在视觉皮层成熟之前进行,对CEP290相关的Leber先天性黑蒙先天性缺乏空间视觉的干预可能会导致更好的结果。
UNASSIGNED: To understand consequences of reconstituting cone photoreceptor function in congenital binocular blindness resulting from mutations in the centrosomal protein 290 (CEP290) gene.
UNASSIGNED: Phase 1b/2 open-label, multicenter, multiple-dose, dose-escalation
trial.
UNASSIGNED: A homogeneous subgroup of 5 participants with light perception (LP) vision at the time of enrollment (age range, 15-41 years) selected for detailed analyses. Medical histories of 4 participants were consistent with congenital binocular blindness, whereas 1 participant showed evidence of spatial vision in early life that was later lost.
UNASSIGNED: Participants received a single intravitreal injection of sepofarsen (160 or 320 μg) into the study eye.
UNASSIGNED: Full-field stimulus testing (FST), visual acuity (VA), and transient pupillary light reflex (TPLR) were measured at baseline and for 3 months after the injection.
UNASSIGNED: All 5 participants with LP vision demonstrated severely abnormal FST and TPLR findings. At baseline, FST threshold estimates were 0.81 and 1.0 log cd/m2 for control and
study eyes, respectively. At 3 months,
study eyes showed a large mean improvement of -1.75 log versus baseline (P < 0.001), whereas untreated control eyes were comparable with baseline. Blue minus red FST values were not different than 0 (P = 0.59), compatible with cone mediation of remnant vision. At baseline, TPLR response amplitude and latency estimates were 0.39 mm and 0.72 seconds, respectively, for control eyes, and 0.28 mm and 0.78 seconds, respectively, for
study eyes. At 3 months,
study eyes showed a mean improvement of 0.44 mm in amplitude and a mean acceleration of 0.29 seconds in latency versus baseline (P < 0.001), whereas control eyes showed no significant change versus baseline. Specialized tests performed in 1 participant confirmed and extended the standardized results from all 5 participants.
UNASSIGNED: By subjective and objective evidence, intravitreal sepofarsen provides improvement of light sensitivity for individuals with LP vision. However, translation of increased light sensitivity to improved spatial vision may occur preferentially in those with a history of visual experience during early neurodevelopment. Interventions for congenital lack of spatial vision in CEP290-associated Leber congenital amaurosis may lead to better results if performed before visual cortex maturity.